Evidence map›Paper›PMID 30096827›Full record

ArticleNutrients2018

Chrysin Ameliorates Malfunction of Retinoid Visual Cycle through Blocking Activation of AGE-RAGE-ER Stress in Glucose-Stimulated Retinal Pigment Epithelial Cells and Diabetic Eyes.

Min-Kyung Kang, Eun-Jung Lee, Yun-Ho Kim, Dong Yeon Kim, Hyeongjoo Oh, Soo-Il Kim, Young-Hee Kang

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Glycative stress as a cause of macular degeneration.Progress in retinal and eye research · 2024
    Review
  8. Review
  9. Article
  10. Review
  11. Protective Effect ofAntioxidants (Basel, Switzerland) · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Min-Kyung KangDepartment of Food Science and Nutrition, Hallym University, Chuncheon 24252, Korea. mitoly@hallym.ac.kr.
Eun-Jung LeeDepartment of Food Science and Nutrition, Hallym University, Chuncheon 24252, Korea. reydmswjd@naver.com.
Yun-Ho KimDepartment of Food Science and Nutrition, Hallym University, Chuncheon 24252, Korea. royalskim@hallym.ac.kr.
Dong Yeon KimDepartment of Food Science and Nutrition, Hallym University, Chuncheon 24252, Korea. ehddus3290@naver.com.
Hyeongjoo OhDepartment of Food Science and Nutrition, Hallym University, Chuncheon 24252, Korea. ohhyeongju@gmail.com.
Soo-Il KimDepartment of Food Science and Nutrition, Hallym University, Chuncheon 24252, Korea. ky4850@naver.com.
Young-Hee KangDepartment of Food Science and Nutrition, Hallym University, Chuncheon 24252, Korea. yhkang@hallym.ac.kr.
Hallym University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes-associated visual cycle impairment has been implicated in diabetic retinopathy, and chronic hyperglycemia causes detrimental effects on visual function. Chrysin, a naturally occurring flavonoid found in various herbs, has anti-inflammatory, antioxidant, and neuroprotective properties. The goal of the current study was to identify the retinoprotective role of chrysin in maintaining robust retinoid visual cycle-related components. The in vitro study employed human retinal pigment epithelial (RPE) cells exposed to 33 mM of glucose or advanced glycation end products (AGEs) in the presence of 1⁻20 μM chrysin for three days. In the in vivo study, 10 mg/kg of chrysin was orally administrated to db/db mice. Treating chrysin reversed the glucose-induced production of vascular endothelial growth factor, insulin-like growth factor-1, and pigment epithelium-derived factor (PEDF) in RPE cells. The outer nuclear layer thickness of chrysin-exposed retina was enhanced. The oral gavage of chrysin augmented the levels of the visual cycle enzymes of RPE65, lecithin retinol acyltransferase (LRAT), retinol dehydrogenase 5 (RDH5), and rhodopsin diminished in db/db mouse retina. The diabetic tissue levels of the retinoid binding proteins and the receptor of the cellular retinol-binding protein, cellular retinaldehyde-binding protein-1, interphotoreceptor retinoid-binding protein and stimulated by retinoic acid 6 were restored to those of normal mouse retina. The presence of chrysin demoted AGE secretion and AGE receptor (RAGE) induction in glucose-exposed RPE cells and diabetic eyes. Chrysin inhibited the reduction of PEDF, RPE 65, LRAT, and RDH5 in 100 μg/mL of AGE-bovine serum albumin-exposed RPE cells. The treatment of RPE cells with chrysin reduced the activation of endoplasmic reticulum (ER) stress. Chrysin inhibited the impairment of the retinoid visual cycle through blocking ER stress via the AGE-RAGE activation in glucose-stimulated RPE cells and diabetic eyes. This is the first study demonstrating the protective effects of chrysin on the diabetes-associated malfunctioned visual cycle.

Indexed as

AnimalsCell LineDiabetic RetinopathyDisease Models, AnimalEndoplasmic Reticulum StressEpithelial CellsEye ProteinsFlavonoidsGlucoseGlycation End Products, AdvancedHumansMaleMice, Inbred C57BLProtective AgentsReceptor for Advanced Glycation End ProductsRetinal Pigment Epitheliumadvanced glycation end products-bovine serum albuminAGER protein, humanAger protein, mousechrysinEye ProteinsFlavonoidsGlucoseGlycation End Products, AdvancedProtective AgentsReceptor for Advanced Glycation End ProductsSerum Albumin, Bovineadvanced glycation end productschyrsindiabetic retinopathyendoplasmic reticulumretinal pigment epitheliumvisual cycle

Identifiers

PMID30096827
PMCPMC6116048
OpenAlexW2885666656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.